Synopsys (NASDAQ:SNPS - Get Free Report) will likely be issuing its Q3 2026 results after the market closes on Wednesday, August 26th. Analysts expect Synopsys to post earnings of $3.67 per share and revenue of $2.4377 billion for the quarter. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Individuals can check the company's upcoming Q3 2026 earning report for the latest details on the call scheduled for Wednesday, August 26, 2026 at 5:00 PM ET.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The company had revenue of $2.28 billion during the quarter, compared to analysts' expectations of $2.25 billion. During the same period last year, the business earned $3.67 EPS. The business's quarterly revenue was up 41.9% on a year-over-year basis. On average, analysts expect Synopsys to post $11 EPS for the current fiscal year and $13 EPS for the next fiscal year.
Synopsys Stock Performance
Shares of NASDAQ SNPS opened at $404.41 on Wednesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. The stock has a 50 day moving average price of $423.21 and a 200 day moving average price of $441.54. The stock has a market capitalization of $77.44 billion, a PE ratio of 93.61, a price-to-earnings-growth ratio of 2.48 and a beta of 1.23. Synopsys has a 52 week low of $366.00 and a 52 week high of $624.82.
Analysts Set New Price Targets
Several equities analysts have commented on SNPS shares. Rosenblatt Securities upped their price objective on shares of Synopsys from $530.00 to $575.00 and gave the company a "buy" rating in a report on Tuesday, May 26th. Piper Sandler upgraded shares of Synopsys from a "neutral" rating to an "overweight" rating and raised their target price for the stock from $450.00 to $550.00 in a research note on Tuesday, June 23rd. Zacks Research raised shares of Synopsys from a "hold" rating to a "strong-buy" rating in a report on Tuesday, June 30th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Synopsys in a research note on Monday, June 8th. Finally, Bank of America increased their price target on shares of Synopsys from $515.00 to $600.00 and gave the company a "buy" rating in a report on Thursday, May 28th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, Synopsys has an average rating of "Moderate Buy" and a consensus price target of $565.06.
Get Our Latest Stock Analysis on Synopsys
Insider Activity at Synopsys
In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the firm's stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm's stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by insiders.
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the stock. Sunbelt Securities Inc. lifted its position in shares of Synopsys by 1,250.0% during the 4th quarter. Sunbelt Securities Inc. now owns 243 shares of the semiconductor company's stock valued at $114,000 after acquiring an additional 225 shares during the period. Axxcess Wealth Management LLC grew its holdings in Synopsys by 39.4% in the fourth quarter. Axxcess Wealth Management LLC now owns 4,581 shares of the semiconductor company's stock worth $2,152,000 after purchasing an additional 1,295 shares during the period. Corient Private Wealth LLC increased its stake in Synopsys by 31.0% in the fourth quarter. Corient Private Wealth LLC now owns 35,155 shares of the semiconductor company's stock valued at $16,513,000 after purchasing an additional 8,322 shares in the last quarter. Mercer Global Advisors Inc. ADV increased its stake in Synopsys by 1.3% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 7,534 shares of the semiconductor company's stock valued at $3,539,000 after purchasing an additional 96 shares in the last quarter. Finally, Vident Advisory LLC raised its holdings in shares of Synopsys by 35.6% during the fourth quarter. Vident Advisory LLC now owns 36,721 shares of the semiconductor company's stock valued at $17,249,000 after purchasing an additional 9,633 shares during the period. 85.47% of the stock is owned by institutional investors.
Synopsys Company Profile
(
Get Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.